FDA approves Teva migraine drug
September 17, 2018 at 11:49 AM EDT
The approval sent Teva's stock up 5.2 percent to $24.04 per share in late morning trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.